Thanks Easka. No not a bad thing at all. Manufacturing is a critical issue for this space. It will be very difficult for other competitors to match the infrastructure they build which will be a competitive advantage. I recall reading in the Amgen sub-license that Kite would be the manufacturing arm. This way they capture more of the value.
Market Data 
Markets 
